View More Recent Stories

Sep 29, 2016 08:30AM Critical Outcome Technologies Reports Fiscal 2017 First Quarter Financial and Operating Results
Sep 13, 2016 08:30AM Critical Outcome Appoints Dr. Bharatt Chowrira to Its Board of Directors
Aug 23, 2016 08:30AM Critical Outcome Technologies Announces the Opening of Its U.S. Headquarters
Aug 3, 2016 07:30AM Critical Outcome Technologies Reports Year-End Financial & Operating Results
Jul 12, 2016 09:17AM Critical Outcome Initiates Third Cohort in Phase 1 Study of COTI-2 in Gynecologic Cancers
Jul 6, 2016 08:30AM Critical Outcome Technologies Awards Stock Options
Jun 15, 2016 09:15AM Critical Outcome Technologies Appoints Experienced Industry Executive as New President
Jun 8, 2016 07:05PM Critical Outcome Announces No Material Change
Jun 6, 2016 08:30AM Critical Outcome Activates Second Clinical Trial Site for Its COTI-2 Gynecological Cancer Study
Jun 3, 2016 09:07AM Critical Outcome Technologies Receives $1.6M From Warrant Exercises
Jun 1, 2016 08:30AM Critical Outcome to Present at International Li-Fraumeni Syndrome Conference and at BIO International Convention
May 24, 2016 08:30AM Critical Outcome Receives Additional Patent Protection for Potential Transformational P53 Cancer Treatment
May 2, 2016 08:00AM Critical Outcome Technologies Announces Additional Funding Through Warrant Exercises
Apr 27, 2016 08:00AM Critical Outcome Technologies Augments Advisory Board Drug Development Experience
Apr 19, 2016 08:30AM Critical Outcome Commences Treatment of Second Cohort in Phase 1 Study of COTI-2 in Gynecologic Cancers
Mar 22, 2016 02:41PM Critical Outcome Technologies Provides Market Update
Mar 17, 2016 08:30AM Critical Outcome Technologies Announces Funding Received Through Warrant Exercises
Mar 14, 2016 09:13AM Critical Outcome Launches Rosalind -- A Precision Medicine Platform Designed to Provide Cancer Treatment Options
Mar 11, 2016 04:05PM Critical Outcome Technologies Reports Fiscal 2016 Third Quarter Financial and Operating Results
Feb 16, 2016 08:30AM Critical Outcome Treats First Patient in Phase 1 Study of COTI-2 in Gynecologic Cancers
Jan 8, 2016 05:26PM Critical Outcome Technologies Awards Stock Options
Dec 16, 2015 04:05PM Critical Outcome Technologies Reports Second Quarter Financial and Operating Results
Dec 10, 2015 08:30AM COTI-2 Moves Into Human Testing
Dec 2, 2015 09:46AM Critical Outcome Technologies Pursues Orphan Drug Designation for COTI-2 Intended to Treat Li-Fraumeni Syndrome
Oct 19, 2015 09:36AM Critical Outcome Technologies Awards Stock Options
Oct 16, 2015 05:23PM Critical Outcome Technologies Provides Update on Recent Milestone Achievements and Future Strategic Objectives at Annual General Meeting
Sep 29, 2015 09:14AM Critical Outcome Technologies Reports First Quarter Financial and Operating Results
Sep 1, 2015 04:30PM Critical Outcome Technologies Provides Clarification Regarding Investor Relations Engagement
Sep 1, 2015 08:30AM Critical Outcome Technologies Strengthens Its Investor Relations Capabilities
Aug 28, 2015 08:16PM Critical Outcome Technologies Reports Year-End Financial and Operating Results
Aug 4, 2015 05:00PM Critical Outcome Technologies Completes Private Placement Supporting Its Phase 1 Clinical Trial for p53-Dependent Gynecological Cancers
May 26, 2015 08:30AM FDA Grants IND to Critical Outcome Technologies for COTI-2, the Company's Activator of Mutant p53 Protein
May 14, 2015 08:30AM Critical Outcome Technologies Strengthens Its Board
May 11, 2015 08:30AM Critical Outcome Technologies Adds First European Patent to Growing Intellectual Property Protection for COTI-2
Apr 27, 2015 08:30AM Critical Outcome Technologies Files Investigational New Drug Application With the FDA for COTI-2
Apr 15, 2015 08:30AM Critical Outcome Technologies Receives First U.S. Patent for Next Generation HIV Treatment
Apr 2, 2015 09:00AM Critical Outcome Technologies Inc. Strengthens Its Investor Relations Outreach
Mar 23, 2015 08:30AM Critical Outcome Technologies Establishes Advisory Board for the Clinical Development of COTI-2
Mar 20, 2015 04:05PM Critical Outcome Technologies Reports Fiscal 2015 Third Quarter Results
View More Recent Stories